664 related articles for article (PubMed ID: 28436720)
1. Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis.
Gui YJ; Liao CX; Liu Q; Guo Y; Yang T; Chen JY; Wang YT; Hu JH; Xu DY
Eur J Prev Cardiol; 2017 Jun; 24(9):907-916. PubMed ID: 28436720
[TBL] [Abstract][Full Text] [Related]
2. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.
Zhang X; Xing L; Jia X; Pang X; Xiang Q; Zhao X; Ma L; Liu Z; Hu K; Wang Z; Cui Y
Cardiovasc Ther; 2020; 2020():3987065. PubMed ID: 32411300
[TBL] [Abstract][Full Text] [Related]
3. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
[TBL] [Abstract][Full Text] [Related]
4. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
Geng Q; Ren J; Chen H; Lee C; Liang W
Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
[TBL] [Abstract][Full Text] [Related]
5. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A;
Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.
Geng Q; Ren J; Chen H; Lee C; Liang W
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):219-26. PubMed ID: 23324122
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis.
Choi HD; Chae SM
Medicine (Baltimore); 2018 Dec; 97(50):e13593. PubMed ID: 30558030
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials.
Sahebkar A; Kotani K; Serban C; Ursoniu S; Mikhailidis DP; Jones SR; Ray KK; Blaha MJ; Rysz J; Toth PP; Muntner P; Lip GY; Banach M;
Atherosclerosis; 2015 Aug; 241(2):433-42. PubMed ID: 26074317
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy and plasma vitamin E concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sahebkar A; Simental-Mendía LE; Ferretti G; Bacchetti T; Golledge J
Atherosclerosis; 2015 Dec; 243(2):579-88. PubMed ID: 26539697
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia.
Arai H; Yamashita S; Yokote K; Araki E; Suganami H; Ishibashi S;
Atherosclerosis; 2017 Jun; 261():144-152. PubMed ID: 28410749
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of fibrate-statin combination therapy compared to fibrate monotherapy in patients with dyslipidemia: a meta-analysis.
Choi HD; Shin WG; Lee JY; Kang BC
Vascul Pharmacol; 2015; 65-66():23-30. PubMed ID: 25451563
[TBL] [Abstract][Full Text] [Related]
12. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.
Enger C; Gately R; Ming EE; Niemcryk SJ; Williams L; McAfee AT
Am J Cardiol; 2010 Dec; 106(11):1594-601. PubMed ID: 21094360
[TBL] [Abstract][Full Text] [Related]
14. The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without Type 2 diabetes.
Meex RC; Phielix E; Schrauwen-Hinderling VB; Moonen-Kornips E; Schaart G; Schrauwen P; Hesselink MK
Clin Sci (Lond); 2010 Jun; 119(7):293-301. PubMed ID: 20465545
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
[TBL] [Abstract][Full Text] [Related]
16. Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.
Sahebkar A; Serban C; Mikhailidis DP; Undas A; Lip GY; Muntner P; Bittner V; Ray KK; Watts GF; Hovingh GK; Rysz J; Kastelein JJ; Banach M;
Thromb Haemost; 2015 Aug; 114(3):546-57. PubMed ID: 26017749
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
[TBL] [Abstract][Full Text] [Related]
19. Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.
Sharma M; Ansari MT; Abou-Setta AM; Soares-Weiser K; Ooi TC; Sears M; Yazdi F; Tsertsvadze A; Moher D
Ann Intern Med; 2009 Nov; 151(9):622-30. PubMed ID: 19884623
[TBL] [Abstract][Full Text] [Related]
20. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
van Stee MF; de Graaf AA; Groen AK
Cardiovasc Diabetol; 2018 Jun; 17(1):94. PubMed ID: 29960584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
